Development of an in vitro potency assay for anti-anthrax lethal toxin neutralizing antibodies.

Toxins
Gail WhitingSjoerd Rijpkema

Abstract

Lethal toxin (LT) of Bacillus anthracis reduces the production of a number of inflammatory mediators, including transcription factors, chemokines and cytokines in various human cell lines, leading to down-regulation of the host inflammatory response. Previously we showed that the reduction of interleukin-8 (IL-8) is a sensitive marker of LT-mediated intoxication in human neutrophil-like NB-4 cells and that IL-8 levels are restored to normality when therapeutic monoclonal antibodies (mAb) with toxin-neutralising (TN) activity are added. We used this information to develop cell-based assays that examine the effects of TN therapeutic mAbs designed to treat LT intoxication and here we extend these findings. We present an in vitro assay based on human endothelial cell line HUVEC jr2, which measures the TN activity of therapeutic anti-LT mAbs using IL-8 as a marker for intoxication. HUVEC jr2 cells have the advantage over NB-4 cells that they are adherent, do not require a differentiation step and can be used in a microtitre plate format and therefore can facilitate high throughput analysis. This human cell-based assay provides a valid alternative to the mouse macrophage assay as it is a more biologically relevant model of the effect...Continue Reading

References

May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S H Leppla
May 23, 1998·Science·N S DuesberyG F Vande Woude
Jan 11, 2003·The Journal of Biological Chemistry·Arun P ChopraNicholas S Duesbery
Jul 23, 2003·In Vitro Cellular & Developmental Biology. Animal·Roland A FleckGlyn N Stacey
Jul 24, 2003·The American Journal of Pathology·Jeannette GuarnerUNKNOWN Inhalational Anthrax Pathology Working Group
Sep 4, 2003·The Journal of Clinical Investigation·Mahtab MoayeriStephen H Leppla
Oct 23, 2003·Annual Review of Cell and Developmental Biology·R John Collier, John A T Young
Mar 18, 2004·Biologicals : Journal of the International Association of Biological Standardization·Donna HeringJudith Pace-Templeton
Mar 24, 2004·Current Opinion in Microbiology·Mahtab Moayeri, Stephen H Leppla
Dec 22, 2004·The Journal of Experimental Medicine·Jin Mo ParkMichael Karin
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hui FangDavid M Frucht
May 28, 2005·The American Journal of Pathology·Jason M WarfelFelice D'Agnillo
Aug 10, 2005·The Journal of Infectious Diseases·Russell L DuringFrederick S Southwick
Oct 26, 2005·Biochemical and Biophysical Research Communications·Amber D SteeleFelice D'Agnillo
Oct 13, 2006·Trends in Cell Biology·Guido Posern, Richard Treisman
Apr 21, 2007·The EMBO Journal·Russell L DuringFrederick S Southwick
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Richard StebbingsStephen Poole
May 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jason M Warfel, Felice D'Agnillo
Jul 16, 2008·Biochemical and Biophysical Research Communications·Helen V BarsonSjoerd Rijpkema
Sep 10, 2008·Nature Biotechnology·Jason MathenyBradley Smith
Jul 20, 2010·Biochemical and Biophysical Research Communications·Zachary L NewmanMahtab Moayeri
Nov 10, 2011·Toxins·Zhaochun ChenRobert Purcell

❮ Previous
Next ❯

Citations

Nov 25, 2014·Molecular Carcinogenesis·Geetika SethiAndrew K Godwin

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
PCRs
ELISA

Software Mentioned

Combistats

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.